Physician profile
Howard B Goldstein
NPI 1043316912
$5,936.33
in general payments reported to CMS, 2019-2025
23 companies · $1,273 in 2025
The $1,273 reported for 2025 was more than what 75% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $45.78 · 2021: $519 · 2022: $709 · 2023: $1,472 · 2024: $936 · 2025: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,199 · Consulting Fee: $800 · Honoraria: $650 · Travel and Lodging: $16.44 · Entertainment: $15.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.80 |
| Consulting Fee | $800.00 |
| Honoraria | $650.00 |
| Travel and Lodging | $16.44 |
| Entertainment | $15.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,435.52 | 2019-2025 | Solyx Sis System, Solyx Blue, Axonics |
| Medtronic, INC. | $829.89 | 2021-2025 | Interstim |
| Becton, Dickinson and Company | $650.00 | 2025 | Avitene Ultrafoam |
| Caldera Medical, INC | $595.88 | 2019-2022 | |
| Coloplast Corp | $565.09 | 2019-2025 | Altis, Restorelle |
| Astellas Pharma US INC | $526.45 | 2019-2023 | Myrbetriq, Veozah |
| Abbvie INC. | $266.84 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $188.14 | 2023-2025 | Gemtesa |
| Mission Pharmacal Company | $144.77 | 2019-2024 | Uribel, Uribel Tabs |
| Axonics, INC. | $135.05 | 2022-2024 | Axonics |
| Renovia INC | $105.60 | 2019-2020 | |
| Urovant Sciences INC | $98.61 | 2021-2022 | |
| Pfizer INC. | $71.77 | 2021-2022 | |
| Therapeuticsmd, INC. | $65.66 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $48.43 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $40.68 | 2023 | Ecoin Device Kit |
| 180 Medical, INC. | $38.51 | 2022-2023 | Speedicath |
| Allergan, INC. | $31.13 | 2019 | |
| Millicent US INC | $30.25 | 2023-2024 | Femring, Intrarosa |
| Abbott Laboratories | $23.08 | 2022 | |
| Rochester Medical Corporation | $16.26 | 2019 | |
| Provepharm INC. | $15.33 | 2024 | Bludigo |
| Medtronic USA, INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.